Bernice Kuca serves as Executive at CoLucid Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Bernice Kuca has executed 5 insider transactions totaling $55.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 1, 2017 involved transacting 2,729 shares valued at $126.9K.
Bernice Kuca currently holds 40,086 shares of CoLucid Pharmaceuticals, Inc. (CLCD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bernice Kuca has been a net seller of CLCD stock. They have purchased $0 and sold $55.2K worth of shares.
Bernice Kuca's most recent insider trade was on Mar 1, 2017, when they sold 2,729 shares at $46.50 per share.
Get notified when new Form 4 filings are submitted
| $46.50 |
| Discretionary |
| Jan 3, 2017 | CLCD | $28.0K | Sale | 772 | $36.25 | Discretionary |
| Dec 1, 2016 | CLCD | $27.2K | Sale | 772 | $35.22 | Discretionary |
| Mar 4, 2016 | CLCD | $0 | Award | 37,500 | $N/A | Discretionary |